The more complex classification of PD-L1 in HCC tissues and higher levels of spatial and cellular heterogeneity may affect the reliability and reproducibility of PD-L1 as a predictor of ICIs efficacy [33]. The gene discussed is CD274; the disease is hepatocellular carcinoma.